B.C. government won't fund drug for rare disease for nine-year-old girl

VICTORIA - The British Columbia government says it will no longer fund an expensive drug for a nine-year-old girl who has a rare and terminal condition.
Health Minister Josie Osborne says in a statement that Charleigh Pollock's condition with Batten Disease has reached the point where she meets the criteria to discontinue the use of Brineura.
The girl has been receiving the drug therapy since 2019 at a cost of about $1 million a year.
ARTICLE CONTINUES BELOW
She is the only person in the province, and one of 13 children in Canada, who has the genetic and fatal disorder that results in multiple seizures a day.
The statement says clinical evidence shows that once a patient has declined in motor skills and language functions by a certain amount, the drug is no longer a benefit in slowing the progression of the disease.
Osborne says a Canada Drug Agency review of the latest research on the girl's disease found there was no evidence to support its continuing drug coverage, given the advanced stage of her condition.
This report by The Canadian Press was first published June 18, 2025.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Winnipeg Free Press

a day ago

• Winnipeg Free Press

Control zones set up in Fraser Valley, B.C., after Newcastle disease detected

CHILLIWACK – The Canadian Food Inspection Agency has put up controls on the movements of birds around two commercial poultry farms experiencing the first outbreaks of virulent Newcastle disease in Canada in more than 50 years. The establishment of the primary control zones in the Fraser Valley means that birds, byproducts and items that have contacted the birds cannot be moved within or through the areas without permission. The agency says the virus affects both wild and domestic birds and can cause pink eye in humans, and birds at the infected farms must be culled. The agency says that before the disease was detected in B.C. this month, including at a commercial pigeon operation, the last infections in Canada were reported in 1973. The CFIA says the ailment is of great concern to the world's agricultural community since it's highly contagious and threatens poultry. It says Newcastle disease can decrease egg production in domestic birds and cause high numbers of sudden deaths in a flock, while wild birds can develop wing paralysis and be left unable to fly. It says the risk to humans is low if gloves are worn while handling infected birds, and that the disease was rarely found to kill wild birds before 1990. This report by The Canadian Press was first published June 20, 2025.

Winnipeg Free Press

2 days ago

• Winnipeg Free Press

Quebec issues warning about diseases from ticks, mosquitoes

QUÉBEC – Quebec's Health Department is warning people to stay vigilant about tick and mosquito bites as summer begins. The department says ticks and mosquitoes can carry Lyme disease, West Nile virus, and California serogroup viruses, among others. As well, the province says the warming climate is allowing ticks to survive more easily than before. It says there are several ways to protect against disease, such as using a DEET- or icaridin-based mosquito repellent and wearing light-coloured, lightweight clothing. To prevent tick bites, people should stick to walking trails and avoid tall grass. Lyme disease is the most common tick-borne illness in Quebec. Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. From Jan. 1 to Oct. 26, 2024, 681 cases of Lyme disease were reported in Quebec, compared to 652 cases for all of 2023. There were 125 cases in 2014, 160 in 2015, and 177 in 2016. This report by The Canadian Press was first published June 20, 2025.

CBC

2 days ago

• CBC

Vancouver Island family heartbroken as B.C. stops funding $1M drug for girl with terminal condition

A Vancouver Island family is in shock after learning the British Columbia government will stop funding an extremely expensive medication their young daughter needs for a rare genetic condition. Nine-year-old Charleigh Pollock is the only person in B.C. with Batten disease, or neuronal ceroid lipofuscinosis type 2 (CLN2). It's a rare and terminal genetic disorder that causes multiple seizures daily, eventually causing brain damage. Pollock's mother, Jori Fales, said the family is still processing the news, announced Wednesday, that the B.C. government will pull funding for Pollock's access to Brineura, a $1-million-per-year medication which is given through an infusion of fluid to the brain to slow the progression of CLN2. "Emotions have gone from sheer heartbreak to anger to sadness; it's just been a roller-coaster the last 24 hours," Fales said. Thursday marked Pollock's last infusion of Brineura. Fales called the government's decision to pull funding with one day's notice before the last infusion "a little heartless." She said her daughter has been let down. "At the end of the day, it should have always been the decision of her medical care team, and her family and Charleigh. And none of that has happened here." On Thursday, B.C. Minister of Health Josie Osborne said it was a tough decision to end the funding. She said the cost of the medication had nothing to do with the reason the funding was pulled, but that it was determined Pollock's condition had deteriorated to the point where she met "discontinuation criteria" for Brineura. "Clinical evidence shows that once a patient has declined in their motor and language functions by a certain amount, Brineura no longer has the benefit of slowing down the progression of the disease, although patients can continue to live on into mid-adolescence," Osborne said. Fales denied that her daughter's condition has worsened. "Charleigh is not in advanced progression of her disease. This is simply not true," she said. Dr. Ineka Whiteman, the head of research and medical affairs for the Batten Disease Support and Research Association U.S. and Australia and head of the Batten Disease Global Research Initiative, called the B.C. government's decision "appalling." She expressed frustration with the provincial government's emphasis on criteria to discontinue the medicine, which she said is based on old clinical trials. She added other families around the world are becoming concerned their access to the medication may also be reconsidered. "This is not just about a single child. This is really setting a very, very dangerous precedent." Fales said she plans to share her daughter's journey and advocate for others dealing with the disease.